Clinical Trial Update: Therapeutic Effect of Low-dose Prednisone Combined With MMF and FK506 in Focal Segmental Glomerulosclerosis [NA]

View source ↗

Summary

This clinical trial update describes evaluating a combination of low-dose prednisone, mycophenolate mofetil, and tacrolimus for focal segmental glomeruloscleros…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Focal Segmental Glomerulosclerosis

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)
• PREDNISONE (Prednisone)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Xi'an Jiaotong University | Conditions: Focal Segmental Glomerulosclerosis | NA | Status: UNKNOWN